216 related articles for article (PubMed ID: 16022169)
1. An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several.
Kelly PJ; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):641-58. PubMed ID: 16022169
[TBL] [Abstract][Full Text] [Related]
2. Group-sequential methods for adaptive seamless phase II/III clinical trials.
Stallard N
J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
[TBL] [Abstract][Full Text] [Related]
3. A comparison of methods for adaptive treatment selection.
Friede T; Stallard N
Biom J; 2008 Oct; 50(5):767-81. PubMed ID: 18932136
[TBL] [Abstract][Full Text] [Related]
4. Sequential designs for phase III clinical trials incorporating treatment selection.
Stallard N; Todd S
Stat Med; 2003 Mar; 22(5):689-703. PubMed ID: 12587100
[TBL] [Abstract][Full Text] [Related]
5. A seamless phase II/III design with sample-size re-estimation.
Bischoff W; Miller F
J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
[TBL] [Abstract][Full Text] [Related]
6. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
7. A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information.
Stallard N
Stat Med; 2010 Apr; 29(9):959-71. PubMed ID: 20191605
[TBL] [Abstract][Full Text] [Related]
8. Seamless Phase II/III combination study through response adaptive randomization.
Wang L; Cui L
J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
[TBL] [Abstract][Full Text] [Related]
9. An alternative phase II/III design for continuous endpoints.
Huang WS; Liu JP; Hsiao CF
Pharm Stat; 2011; 10(2):105-14. PubMed ID: 20186724
[TBL] [Abstract][Full Text] [Related]
10. Meta-analyses and adaptive group sequential designs in the clinical development process.
Jennison C; Turnbull BW
J Biopharm Stat; 2005; 15(4):537-58. PubMed ID: 16022162
[TBL] [Abstract][Full Text] [Related]
11. Dose selection in seamless phase II/III clinical trials based on efficacy and safety.
Kimani PK; Stallard N; Hutton JL
Stat Med; 2009 Mar; 28(6):917-36. PubMed ID: 19152231
[TBL] [Abstract][Full Text] [Related]
12. A flexible design for multiple armed screening trials.
Sargent DJ; Goldberg RM
Stat Med; 2001 Apr; 20(7):1051-60. PubMed ID: 11276035
[TBL] [Abstract][Full Text] [Related]
13. A practical comparison of group-sequential and adaptive designs.
Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
[TBL] [Abstract][Full Text] [Related]
14. Targeting population entering phase III trials: a new stratified adaptive phase II design.
Tournoux-Facon C; De Rycke Y; Tubert-Bitter P
Stat Med; 2011 Apr; 30(8):801-11. PubMed ID: 21432875
[TBL] [Abstract][Full Text] [Related]
15. A flexible multi-stage design for phase II oncology trials.
Tan MT; Xiong X
Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
[TBL] [Abstract][Full Text] [Related]
16. Designing a series of decision-theoretic phase II trials in a small population.
Hee SW; Stallard N
Stat Med; 2012 Dec; 31(30):4337-51. PubMed ID: 22927289
[TBL] [Abstract][Full Text] [Related]
17. An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure.
Taylor DJ; Grobler A; Abdool Karim SS
Clin Trials; 2012 Aug; 9(4):377-84. PubMed ID: 22610168
[TBL] [Abstract][Full Text] [Related]
18. Adaptive Dunnett tests for treatment selection.
Koenig F; Brannath W; Bretz F; Posch M
Stat Med; 2008 May; 27(10):1612-25. PubMed ID: 17876763
[TBL] [Abstract][Full Text] [Related]
19. Two-stage designs for phase II cancer trials with ordinal responses.
Stallard N; Cockey L
Contemp Clin Trials; 2008 Nov; 29(6):896-904. PubMed ID: 18703164
[TBL] [Abstract][Full Text] [Related]
20. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
